This new white paper demonstrates the time-burden on ER+, HER2- mBC patients and their loved ones when going to receive care and the potential difficulty of care when an IM injection is part of their treatment plan. It has been published by Ipsos andLiving Beyond Breast Cancer, and is supported by Lilly.
An at-home option for cervical cancer screening breaks down barriers to care and offers the same level of precision as screening in the clinic.
